Exane Derivatives’s Franco-Nevada FNV Stock Holding History

Exane Derivatives’s Portfolio FNV Stock Details FNV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$4.08K	Sell	31 -1,296	-98%	-$192K	﹤0.01%	401
2022 Q1	$212K	Sell	1,327 -1,779	-57%	-$256K	0.06%	317
2021 Q4	$430K	Buy	3,106 +3,085	+14,690%	+$426K	0.1%	198
2021 Q3	$2.73K	Hold	21	–	–	﹤0.01%	781
2021 Q2	$3.15K	Hold	21	–	–	﹤0.01%	796
2021 Q1	$2.63K	Hold	21	–	–	﹤0.01%	661
2020 Q4	$2.63K	Hold	21	–	–	﹤0.01%	602
2020 Q3	$2.93K	Hold	21	–	–	﹤0.01%	542
2020 Q2	$2.93K	Hold	21	–	–	﹤0.01%	480
2020 Q1	$2.09K	Sell	21 -2,613	-99%	-$284K	﹤0.01%	498
2019 Q4	$270K	Hold	2,634	–	–	0.05%	220
2019 Q3	$240K	Sell	2,634 -5,881	-69%	-$539K	0.04%	221
2019 Q2	$723K	Sell	8,515 -11,999	-58%	-$906K	0.13%	133
2019 Q1	$1.54M	Buy	20,514 +1,999	+11%	+$148K	0.3%	79
2018 Q4	$1.3M	Buy	18,515 +4,999	+37%	+$334K	0.23%	100
2018 Q3	$839K	Buy	13,516 +13,500	+84,375%	+$923K	0.16%	124
2018 Q2	$1.17K	Sell	16 -373	-96%	-$26.4K	﹤0.01%	516
2018 Q1	$25.9K	Buy	389 +225	+137%	+$16.5K	0.01%	388
2017 Q4	$13.1K	Buy	164 +20	+14%	+$1.6K	﹤0.01%	390
2017 Q3	$11.2K	Sell	144 -1,360	-90%	-$104K	﹤0.01%	388
2017 Q2	$109K	Sell	1,504 -1,619	-52%	-$115K	0.02%	267
2017 Q1	$205K	Sell	3,123 -2,059	-40%	-$133K	0.05%	191
2016 Q4	$309K	Buy	5,182 +1,972	+61%	+$120K	0.06%	186
2016 Q3	$224K	Sell	3,210 -7,184	-69%	-$538K	0.03%	198
2016 Q2	$791K	Buy	10,394 +8,483	+444%	+$574K	0.13%	99
2016 Q1	$117K	Buy	1,911 +1,650	+632%	+$88.5K	0.02%	227
2015 Q4	$11.9K	Hold	261	–	–	﹤0.01%	319
2015 Q3	$11.5K	Hold	261	–	–	﹤0.01%	341
2015 Q2	$12.4K	Sell	261 -5,739	-96%	-$291K	﹤0.01%	359
2015 Q1	$291K	Sell	6,000 -1,747	-23%	-$90.9K	0.03%	178
2014 Q4	$381K	Buy	+7,747	New	+$393K	0.05%	159

Other funds holding FNV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

JFL

Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Exane Derivatives's FNV Position: Q2 2022 in Review

Exane Derivatives reduced its Franco-Nevada (FNV) stake by 98% in Q2 2022, selling an estimated $192K and leaving 31 shares worth $4.08K. The position accounts for ﹤0.01% of the portfolio, ranked #401.

Exane Derivatives first reported a position in FNV in Q4 2014 and has held it in 31 quarters since. The position peaked at $1.54M in Q1 2019. 487 funds tracked by Wall St. Rank hold FNV as of Q2 2022.

Exane Derivatives held 31 shares of Franco-Nevada worth $4.08K as of Q2 2022.
Exane Derivatives sold 1,296 Franco-Nevada shares in Q2 2022, an estimated $192K.
Franco-Nevada made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #401 holding.
Exane Derivatives first reported a position in Franco-Nevada in Q4 2014 and has held it in 31 quarters since.
Exane Derivatives's Franco-Nevada position peaked at $1.54M in Q1 2019.
487 funds tracked by Wall St. Rank held Franco-Nevada as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.